Does REBOXETINE Cause Tachycardia? 17 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Tachycardia have been filed in association with REBOXETINE. This represents 9.2% of all adverse event reports for REBOXETINE.
17
Reports of Tachycardia with REBOXETINE
9.2%
of all REBOXETINE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Tachycardia From REBOXETINE?
Of the 17 reports, 2 (11.8%) resulted in death, 2 (11.8%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REBOXETINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does REBOXETINE Cause?
Hyperhidrosis (21)
Off label use (20)
Weight increased (18)
Confusional state (16)
Intentional overdose (16)
Nausea (16)
Drug ineffective (15)
Drug interaction (15)
Sleep disorder (15)
Alanine aminotransferase increased (14)
What Other Drugs Cause Tachycardia?
ACETAMINOPHEN (1,867)
QUETIAPINE (1,843)
CLOZAPINE (1,760)
LEVOTHYROXINE (1,705)
OLANZAPINE (1,389)
METHOTREXATE (1,238)
ADALIMUMAB (1,178)
RITUXIMAB (1,155)
VENLAFAXINE (1,102)
PREDNISONE (1,094)
Which REBOXETINE Alternatives Have Lower Tachycardia Risk?
REBOXETINE vs RECLAST
REBOXETINE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
REBOXETINE vs REGADENOSON
REBOXETINE vs REGORAFENIB
REBOXETINE vs REGORAFENIB\REGORAFENIB